These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 23680377)

  • 21. Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albuminuria in the hypertensive diabetic rat.
    Gin T; Joon TL; Panagiotopoulos S; Cooper M; Taylor H; Jerums G
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):281-9. PubMed ID: 8603832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination therapy with the advanced glycation end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: synergy or redundancy?
    Coughlan MT; Thallas-Bonke V; Pete J; Long DM; Gasser A; Tong DC; Arnstein M; Thorpe SR; Cooper ME; Forbes JM
    Endocrinology; 2007 Feb; 148(2):886-95. PubMed ID: 17110423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
    Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
    Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal and metabolic disorders depend on the renin-angiotensin system in Lyon hypertensive rats associated with diabetes.
    Emonnot L; Cohen R; Lo M
    Am J Hypertens; 2008 Jun; 21(6):657-62. PubMed ID: 18443571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renoprotective effects of combination of angiotensin converting enzyme inhibitor with mycophenolate mofetil in diabetic rats.
    Wu YG; Lin H; Qian H; Zhao M; Qi XM; Wu GZ; Lin ST
    Inflamm Res; 2006 May; 55(5):192-9. PubMed ID: 16830106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement of organ damage by a non-depressor dose of imidapril in diabetic spontaneously hypertensive rats.
    Tomita N; Yamasaki K; Izawa K; Kunugiza Y; Osako MK; Ogihara T; Morishita R
    Int J Mol Med; 2007 Apr; 19(4):571-9. PubMed ID: 17334632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats.
    Chung S; Park CW; Shin SJ; Lim JH; Chung HW; Youn DY; Kim HW; Kim BS; Lee JH; Kim GH; Chang YS
    Nephrol Dial Transplant; 2010 Feb; 25(2):389-99. PubMed ID: 19749146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelin receptor antagonist combined with a calcium channel blocker attenuates renal injury in spontaneous hypertensive rats with diabetes.
    Chen J; Gu Y; Lin F; Yang H; Zhu W; Ma J; Lin S
    Chin Med J (Engl); 2002 Jul; 115(7):972-8. PubMed ID: 12150723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats.
    Volpini RA; da Silva CG; Costa RS; Coimbra TM
    Diabetes Metab Res Rev; 2003; 19(1):43-51. PubMed ID: 12592643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of age and dietary sodium on the cardiovascular and renal effects of ramipril in spontaneously hypertensive rats.
    Teräväinen TL; Mervaala EM; Pörsti I; Laakso J; Vapaatalo H; Karppanen H
    Methods Find Exp Clin Pharmacol; 1997 Jun; 19(5):311-21. PubMed ID: 9379779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition.
    Navarro JF; Milena FJ; Mora C; León C; Claverie F; Flores C; García J
    Kidney Int Suppl; 2005 Dec; (99):S98-102. PubMed ID: 16336586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of angiotensin II in retinal leukostasis in the diabetic rat.
    Chen P; Scicli GM; Guo M; Fenstermacher JD; Dahl D; Edwards PA; Scicli AG
    Exp Eye Res; 2006 Nov; 83(5):1041-51. PubMed ID: 16822509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats.
    Kalender B; Oztürk M; Tunçdemir M; Uysal O; Dagistanli FK; Yegenaga I; Erek E
    Acta Histochem; 2002; 104(2):123-30. PubMed ID: 12086332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
    Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
    Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
    Zoja C; Abbate M; Corna D; Capitanio M; Donadelli R; Bruzzi I; Oldroyd S; Benigni A; Remuzzi G
    Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of angiotensin-converting enzyme inhibition on renal filtration surface area in hypertensive rats.
    Black MJ; Briscoe TA; Dunstan HJ; Bertram JF; Johnston CI
    Kidney Int; 2001 Nov; 60(5):1837-43. PubMed ID: 11703601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expression of type I transforming growth factor beta receptor in renal cortex in streptozotocin-induced diabetic rats and the regulation of benazepril].
    Wu Y; Lin S
    Zhonghua Nei Ke Za Zhi; 1999 Jan; 38(1):9-13. PubMed ID: 11798618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salt blocks the renal benefits of ramipril in diabetic hypertensive rats.
    Fabris B; Jackson B; Johnston CI
    Hypertension; 1991 Apr; 17(4):497-503. PubMed ID: 1826492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of hypertension attenuates albuminuria and renal expression of fibronectin in diabetic spontaneously hypertensive rats.
    Pavan MV; Ghini B; Castro M; Lopes De Faria JB
    Am J Nephrol; 2003; 23(6):422-8. PubMed ID: 14573998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in renal glucose transporters in an animal model of metabolic syndrome.
    Lehnen AM; Leguisamo NM; Dias LD; Pinto GH; Okamoto NM; Machado UF; Schaan BD
    Horm Metab Res; 2013 Oct; 45(11):840-3. PubMed ID: 24062089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.